- Product Details
Keywords
- 99% Dabigatran
- Pharmaceutical Raw Materials Manufacturer
- Dabigatran Manufacturer
Quick Details
- ProName: Factory price Integrase Inhibitor 99% ...
- CasNo: 211914-51-1
- Molecular Formula: C25H25N7O3
- Appearance: White Powder
- Application: For Anti-inflammatory
- DeliveryTime: 2-4 days after confirming your payment...
- PackAge: 100g/ bag, 2 kg/ bag, 25kg/ carton or ...
- Port: Wuhan
- ProductionCapacity: 10000 Metric Ton/Month
- Purity: 99%
- Storage: Store in sealed containers at cool & d...
- Transportation: By DHL, TNT, FedEx, HKEMS, UPS, Etc
- LimitNum: 10 Gram
Superiority
Advantages:
Hubei XinRunde Chemical Co., Ltd is a renowned pharmaceutical manufacturer. We can offer high quality products at competitive price in quick delivery with 100% custom pass guaranteed. Never stop striving to offer our best service is our philosophy. We have Flexible and Untraceable payment terms. As a leading manufacture, our products have been exported to Germany, Norway, Poland, Finland, Spain, UK, France, Russia, USA, Brazil, Mexico, Australia, Japan, Korea, Thailand, Indonesia, Uruguay and many other countries.
1. Quality.Every batch of steroid powders have tobetested by our QC(quality control) before they are allowed to sell.
2. Delivery We have stock, so we can delivery quickly at the very day when receive the payment. Within 24 hours after receiving the payment Lead time 4 or 7 days.
3. Discreet package Safelyand Professionally Disguised Package Guaranteed. For your safety and to insure delivery all products will be packed in a discreet way to prevent any suspicions, no steroids related name will appear on the parcels. high successful delivery rate.
4. Warm after-sale service Any of your question would be solved for the first as soon as possible.
Details
Dabigatran Medication Anticoagulant Drugs CAS No. 211914-51-1
Name | Dabigatran |
Molecular Formula | C25H25N7O3 |
Molecular Weight | 471.51 |
CAS Registry Number | 211914-51-1 |
Description:
Dabigatran is an anticoagulant that can be given by mouth from the class of the direct thrombin inhibitors. It is being studied for various uses and in some cases is an alternative to warfarin as the preferred orally "blood thinner" since it doesn't have to be monitored by blood tests while offering similar results in terms of efficacy. There was no specific way to reverse the anticoagulant effect of dabigatran in the event of a major bleeding event at first,unlike warfarin.A dabigatran antidote has been approved by the FDA in 2015.It was developed by the pharmaceutical company Boehringer Ingelheim.